455 related articles for article (PubMed ID: 15113848)
1. Behavioral characterization of the novel GABAB receptor-positive modulator GS39783 (N,N'-dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine): anxiolytic-like activity without side effects associated with baclofen or benzodiazepines.
Cryan JF; Kelly PH; Chaperon F; Gentsch C; Mombereau C; Lingenhoehl K; Froestl W; Bettler B; Kaupmann K; Spooren WP
J Pharmacol Exp Ther; 2004 Sep; 310(3):952-63. PubMed ID: 15113848
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the anxiolytic-like profile of the GABAB receptor positive modulator CGP7930 in rodents.
Jacobson LH; Cryan JF
Neuropharmacology; 2008 Apr; 54(5):854-62. PubMed ID: 18328507
[TBL] [Abstract][Full Text] [Related]
3. N,N'-Dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine (GS39783) and structurally related compounds: novel allosteric enhancers of gamma-aminobutyric acidB receptor function.
Urwyler S; Pozza MF; Lingenhoehl K; Mosbacher J; Lampert C; Froestl W; Koller M; Kaupmann K
J Pharmacol Exp Ther; 2003 Oct; 307(1):322-30. PubMed ID: 12954816
[TBL] [Abstract][Full Text] [Related]
4. Specific reduction of alcohol's motivational properties by the positive allosteric modulator of the GABAB receptor, GS39783--comparison with the effect of the GABAB receptor direct agonist, baclofen.
Maccioni P; Fantini N; Froestl W; Carai MA; Gessa GL; Colombo G
Alcohol Clin Exp Res; 2008 Sep; 32(9):1558-64. PubMed ID: 18616673
[TBL] [Abstract][Full Text] [Related]
5. The GABAB receptor-positive modulator GS39783 and the GABAB receptor agonist baclofen attenuate the reward-facilitating effects of cocaine: intracranial self-stimulation studies in the rat.
Slattery DA; Markou A; Froestl W; Cryan JF
Neuropsychopharmacology; 2005 Nov; 30(11):2065-72. PubMed ID: 15841108
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo characterization of the novel GABAB receptor positive allosteric modulator, 2-{1-[2-(4-chlorophenyl)-5-methylpyrazolo[1,5-a]pyrimidin-7-yl]-2-piperidinyl}ethanol (CMPPE).
Perdona' E; Costantini VJ; Tessari M; Martinelli P; Carignani C; Valerio E; Mok MH; Zonzini L; Visentini F; Gianotti M; Gordon L; Rocheville M; Corsi M; Capelli AM
Neuropharmacology; 2011; 61(5-6):957-66. PubMed ID: 21756923
[TBL] [Abstract][Full Text] [Related]
7. The positive allosteric modulator GS39783 enhances GABA(B) receptor-mediated inhibition of cyclic AMP formation in rat striatum in vivo.
Gjoni T; Desrayaud S; Imobersteg S; Urwyler S
J Neurochem; 2006 Mar; 96(5):1416-22. PubMed ID: 16441514
[TBL] [Abstract][Full Text] [Related]
8. GABA(B) receptor-positive modulation decreases selective molecular and behavioral effects of cocaine.
Lhuillier L; Mombereau C; Cryan JF; Kaupmann K
Neuropsychopharmacology; 2007 Feb; 32(2):388-98. PubMed ID: 16710312
[TBL] [Abstract][Full Text] [Related]
9. Anxiolytic-like effects of the corticotropin-releasing factor1 (CRF1) antagonist DMP904 [4-(3-pentylamino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)-pyrazolo-[1,5-a]-pyrimidine] administered acutely or chronically at doses occupying central CRF1 receptors in rats.
Lelas S; Wong H; Li YW; Heman KL; Ward KA; Zeller KL; Sieracki KK; Polino JL; Godonis HE; Ren SX; Yan XX; Arneric SP; Robertson DW; Hartig PR; Grossman S; Trainor GL; Taub RA; Zaczek R; Gilligan PJ; McElroy JF
J Pharmacol Exp Ther; 2004 Apr; 309(1):293-302. PubMed ID: 14742750
[TBL] [Abstract][Full Text] [Related]
10. Point mutations in the transmembrane region of GABAB2 facilitate activation by the positive modulator N,N'-dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine (GS39783) in the absence of the GABAB1 subunit.
Dupuis DS; Relkovic D; Lhuillier L; Mosbacher J; Kaupmann K
Mol Pharmacol; 2006 Dec; 70(6):2027-36. PubMed ID: 16966477
[TBL] [Abstract][Full Text] [Related]
11. Reducing effect of the positive allosteric modulators of the GABA(B) receptor, CGP7930 and GS39783, on alcohol intake in alcohol-preferring rats.
Orrù A; Lai P; Lobina C; Maccioni P; Piras P; Scanu L; Froestl W; Gessa GL; Carai MA; Colombo G
Eur J Pharmacol; 2005 Nov; 525(1-3):105-11. PubMed ID: 16289452
[TBL] [Abstract][Full Text] [Related]
12. GABAB1 receptor subunit isoforms exert a differential influence on baseline but not GABAB receptor agonist-induced changes in mice.
Jacobson LH; Bettler B; Kaupmann K; Cryan JF
J Pharmacol Exp Ther; 2006 Dec; 319(3):1317-26. PubMed ID: 16990508
[TBL] [Abstract][Full Text] [Related]
13. Positive allosteric modulators at GABAB receptors exert intrinsic actions and enhance the influence of baclofen on light-induced phase shifts of hamster circadian activity rhythms.
Gannon RL; Millan MJ
Pharmacol Biochem Behav; 2011 Oct; 99(4):712-7. PubMed ID: 21756929
[TBL] [Abstract][Full Text] [Related]
14. The GABA-B positive modulator GS39783 decreases psychostimulant conditioned-reinforcement and conditioned-reward.
Halbout B; Quarta D; Valerio E; Heidbreder CA; Hutcheson DM
Addict Biol; 2011 Jul; 16(3):416-27. PubMed ID: 21309927
[TBL] [Abstract][Full Text] [Related]
15. Annomontine, an alkaloid isolated from Annona purpurea, has anxiolytic-like effects in the elevated plus-maze.
Rejón-Orantes Jdel C; González-Esquinca AR; de la Mora MP; Roldan Roldan G; Cortes D
Planta Med; 2011 Mar; 77(4):322-7. PubMed ID: 20890807
[TBL] [Abstract][Full Text] [Related]
16. Genetic and pharmacological evidence of a role for GABA(B) receptors in the modulation of anxiety- and antidepressant-like behavior.
Mombereau C; Kaupmann K; Froestl W; Sansig G; van der Putten H; Cryan JF
Neuropsychopharmacology; 2004 Jun; 29(6):1050-62. PubMed ID: 15039762
[TBL] [Abstract][Full Text] [Related]
17. Elucidation of the neural circuits activated by a GABA
Pizzo R; O'Leary OF; Cryan JF
Neuropharmacology; 2018 Jul; 136(Pt A):129-145. PubMed ID: 28734870
[TBL] [Abstract][Full Text] [Related]
18. Anxiolytic-like activity of the non-selective galanin receptor agonist, galnon.
Rajarao SJ; Platt B; Sukoff SJ; Lin Q; Bender CN; Nieuwenhuijsen BW; Ring RH; Schechter LE; Rosenzweig-Lipson S; Beyer CE
Neuropeptides; 2007 Oct; 41(5):307-20. PubMed ID: 17637475
[TBL] [Abstract][Full Text] [Related]
19. AIDA influences behavior in rats pretreated with baclofen.
Car H; Nadlewska A; Oksztel R; Wiśniewski K
Pol J Pharmacol; 2001; 53(3):245-52. PubMed ID: 11785925
[TBL] [Abstract][Full Text] [Related]
20. 5-ethoxymethyl-7-fluoro-3-oxo-1,2,3,5-tetrahydrobenzo[4,5]imidazo[1,2a]pyridine-4-N-(2-fluorophenyl)carboxamide (RWJ-51204), a new nonbenzodiazepine anxiolytic.
Dubinsky B; Vaidya AH; Rosenthal DI; Hochman C; Crooke JJ; DeLuca S; DeVine A; Cheo-Isaacs CT; Carter AR; Jordan AD; Reitz AB; Shank RP
J Pharmacol Exp Ther; 2002 Nov; 303(2):777-90. PubMed ID: 12388665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
